SILEXION THERAPEUTICS CORP (SLXN) Stock Cash Flow
NASDAQ:SLXN - Nasdaq - KYG1281K1224 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -18.05M | -16.52M | 263.10K | 580.00K | -760.00K | |||
| Depreciation Amortization | N/A | 25.00K | 45.00K | N/A | N/A | |||
| Change In Working Capital | -2.33M | -1.58M | 87.00K | 360.00K | -470.00K | |||
| Other non cash items | 9.77M | 9.68M | 447.00K | -130.00K | -180.00K | |||
| OPERATING CASH FLOW | -10.58M | -8.40M | -4.53M | 820.00K | -1.41M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -22.00K | -12.00K | N/A | N/A | |||
| Other Investing Activity | N/A | 0.00 | 585.00K | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -22.00K | 573.00K | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -250.00K | 1.65M | 890.00K | 150.00K | |||
| Stock Issued/Repurchased | 12.19M | 3.05M | 522.00K | 0.00 | 118.80M | |||
| Other Financing Activity | N/A | 2.30M | N/A | 0.00 | -2.55M | |||
| FINANCING CASH FLOW | 12.26M | 5.10M | 522.00K | 890.00K | 116.40M | |||
| Exchange Rate Effect | N/A | -61.00K | -230.00K | N/A | N/A | |||
| CHANGE IN CASH | 1.58M | -3.38M | -3.66M | 1.71M | 114.99M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.58M | -8.40M | -4.53M | 820.00K | -1.41M | |||
| Capital Expenditure | N/A | -22.00K | -12.00K | N/A | N/A | |||
| FREE CASH FLOW | -10.61M | -8.42M | -4.54M | 820.00K | -1.41M | |||
All data in USD